Cetuximab, Paclitaxel, Carboplatin, and Radiation for Head and Neck Cancer: A Survival Analysis of a Brown University Oncology Group Phase II Study
- Author
- BIRNBAUM, Ariel1 ; DIPETRILLO, Thomas1 ; FOLLETT, Nancy1 ; SIO, Terence Tai-Weng1 ; SAFRAN, Howard1 ; RATHORE, Ritesh1 ; MERRIAM, Priscilla1 ; WANEBO, Harry1 ; THOMAS, Anthony1 ; PUTHAWALA, Yacoub1 ; JOYCE, Donald1 ; LUPPE, Denise1 ; KHURSHID, Humera1
[1] Brown University Oncology Group, Providence, RI, United States - Source
American journal of clinical oncology. 2014, Vol 37, Num 2, pp 162-166, 5 p ; ref : 38 ref
- CODEN
- AJCODI
- ISSN
- 0277-3732
- Scientific domain
- Medical oncology; Pharmacology drugs
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- cetuximab head and neck cancer radiation
- Keyword (fr)
- Anticancéreux Cancer de la tête et du cou Cancérologie Carboplatine Cétuximab Essai clinique phase II Homme Paclitaxel Survie Toxicité Traitement Tumeur maligne Université Anti-EGFR Anticorps monoclonal Antimitotique Cancer Dérivé du taxane Pathologie ORL Platine II Complexe Récepteur facteur croissance épiderme
- Keyword (en)
- Antineoplastic agent Head and neck cancer Cancerology Carboplatin Cetuximab Phase II trial Human Paclitaxel Survival Toxicity Treatment Malignant tumor University Monoclonal antibody Antimitotic Cancer Taxane derivatives ENT disease Platinum II Complexes Epidermal growth factor receptor
- Keyword (es)
- Anticanceroso Cáncer de cabeza y cuello Cancerología Carboplatino Cetuximab Ensayo clínico fase II Hombre Paclitaxel Sobrevivencia Toxicidad Tratamiento Tumor maligno Universidad Anticuerpo monoclonal Antimitótico Cáncer Taxane derivado ORL patología Platino II Complejo Receptor del factor de crecimiento epidérmico
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors / 002B04C Multiple tumors. Solid tumors. Tumors in childhood (general aspects)
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B10 Otorhinolaryngology. Stomatology / 002B10A Otorhinolaryngology (head neck, general aspects and miscellaneous) / 002B10A01 Tumors
- Discipline
- Otorhinolaryngology. Stomatology Pharmacological treatments Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 28482921
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Cetuximab, Paclitaxel, Carboplatin, and Radiation for Head and Neck Cancer: A Survival Analysis of a Brown University Oncology Group Phase II Study\";s:9:\"\u0000*\u0000jtitle\";s:37:\"American journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:18:\"Am. j. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"37\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"162\";s:8:\"\u0000*\u0000epage\";s:3:\"166\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0277-3732\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BIRNBAUM\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ariel\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:18:\"DIPETRILLO, Thomas\";i:1;s:14:\"FOLLETT, Nancy\";i:2;s:21:\"SIO, Terence Tai-Weng\";i:3;s:14:\"SAFRAN, Howard\";i:4;s:15:\"RATHORE, Ritesh\";i:5;s:18:\"MERRIAM, Priscilla\";i:6;s:13:\"WANEBO, Harry\";i:7;s:15:\"THOMAS, Anthony\";i:8;s:17:\"PUTHAWALA, Yacoub\";i:9;s:13:\"JOYCE, Donald\";i:10;s:13:\"LUPPE, Denise\";i:11;s:16:\"KHURSHID, Humera\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJCODI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Cetuximab, Paclitaxel, Carboplatin, and Radiation for Head and Neck Cancer: A Survival Analysis of a Brown University Oncology Group Phase II Study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Cetuximab, Paclitaxel, Carboplatin, and Radiation for Head and Neck Cancer: A Survival Analysis of a Brown University Oncology Group Phase II Study\";s:9:\"\u0000*\u0000jtitle\";s:37:\"American journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:18:\"Am. j. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"37\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"162\";s:8:\"\u0000*\u0000epage\";s:3:\"166\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0277-3732\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BIRNBAUM\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ariel\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:18:\"DIPETRILLO, Thomas\";i:1;s:14:\"FOLLETT, Nancy\";i:2;s:21:\"SIO, Terence Tai-Weng\";i:3;s:14:\"SAFRAN, Howard\";i:4;s:15:\"RATHORE, Ritesh\";i:5;s:18:\"MERRIAM, Priscilla\";i:6;s:13:\"WANEBO, Harry\";i:7;s:15:\"THOMAS, Anthony\";i:8;s:17:\"PUTHAWALA, Yacoub\";i:9;s:13:\"JOYCE, Donald\";i:10;s:13:\"LUPPE, Denise\";i:11;s:16:\"KHURSHID, Humera\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJCODI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Cetuximab, Paclitaxel, Carboplatin, and Radiation for Head and Neck Cancer: A Survival Analysis of a Brown University Oncology Group Phase II Study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Cetuximab, Paclitaxel, Carboplatin, and Radiation for Head and Neck Cancer: A Survival Analysis of a Brown University Oncology Group Phase II Study\";s:9:\"\u0000*\u0000jtitle\";s:37:\"American journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:18:\"Am. j. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"37\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"162\";s:8:\"\u0000*\u0000epage\";s:3:\"166\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0277-3732\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BIRNBAUM\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ariel\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:18:\"DIPETRILLO, Thomas\";i:1;s:14:\"FOLLETT, Nancy\";i:2;s:21:\"SIO, Terence Tai-Weng\";i:3;s:14:\"SAFRAN, Howard\";i:4;s:15:\"RATHORE, Ritesh\";i:5;s:18:\"MERRIAM, Priscilla\";i:6;s:13:\"WANEBO, Harry\";i:7;s:15:\"THOMAS, Anthony\";i:8;s:17:\"PUTHAWALA, Yacoub\";i:9;s:13:\"JOYCE, Donald\";i:10;s:13:\"LUPPE, Denise\";i:11;s:16:\"KHURSHID, Humera\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJCODI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Cetuximab, Paclitaxel, Carboplatin, and Radiation for Head and Neck Cancer: A Survival Analysis of a Brown University Oncology Group Phase II Study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Cetuximab, Paclitaxel, Carboplatin, and Radiation for Head and Neck Cancer: A Survival Analysis of a Brown University Oncology Group Phase II Study\";s:9:\"\u0000*\u0000jtitle\";s:37:\"American journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:18:\"Am. j. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"37\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"162\";s:8:\"\u0000*\u0000epage\";s:3:\"166\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0277-3732\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BIRNBAUM\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ariel\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:18:\"DIPETRILLO, Thomas\";i:1;s:14:\"FOLLETT, Nancy\";i:2;s:21:\"SIO, Terence Tai-Weng\";i:3;s:14:\"SAFRAN, Howard\";i:4;s:15:\"RATHORE, Ritesh\";i:5;s:18:\"MERRIAM, Priscilla\";i:6;s:13:\"WANEBO, Harry\";i:7;s:15:\"THOMAS, Anthony\";i:8;s:17:\"PUTHAWALA, Yacoub\";i:9;s:13:\"JOYCE, Donald\";i:10;s:13:\"LUPPE, Denise\";i:11;s:16:\"KHURSHID, Humera\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJCODI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Cetuximab, Paclitaxel, Carboplatin, and Radiation for Head and Neck Cancer: A Survival Analysis of a Brown University Oncology Group Phase II Study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Cetuximab, Paclitaxel, Carboplatin, and Radiation for Head and Neck Cancer: A Survival Analysis of a Brown University Oncology Group Phase II Study\";s:9:\"\u0000*\u0000jtitle\";s:37:\"American journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:18:\"Am. j. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"37\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"162\";s:8:\"\u0000*\u0000epage\";s:3:\"166\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0277-3732\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BIRNBAUM\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ariel\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:18:\"DIPETRILLO, Thomas\";i:1;s:14:\"FOLLETT, Nancy\";i:2;s:21:\"SIO, Terence Tai-Weng\";i:3;s:14:\"SAFRAN, Howard\";i:4;s:15:\"RATHORE, Ritesh\";i:5;s:18:\"MERRIAM, Priscilla\";i:6;s:13:\"WANEBO, Harry\";i:7;s:15:\"THOMAS, Anthony\";i:8;s:17:\"PUTHAWALA, Yacoub\";i:9;s:13:\"JOYCE, Donald\";i:10;s:13:\"LUPPE, Denise\";i:11;s:16:\"KHURSHID, Humera\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJCODI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Cetuximab, Paclitaxel, Carboplatin, and Radiation for Head and Neck Cancer: A Survival Analysis of a Brown University Oncology Group Phase II Study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
